MDK and neoplasm: Notably, EHMK‐51‐35 carrier cells infected with AdE3‐midkine or co‐infected with AdE3‐midkine and Ad‐mGM‐CSF induced 80% or 100% of complete tumor reduction, respectively, which increased the survival rates significantly compared to A549 carrier cells (p < 0.05).